WASHINGTON UNIVERSITY SCHOOL OF MEDICINE

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Established: 1891-01-01

Employees: 10K

Market Cap: -

Website: http://www.medschool.wustl.edu

Clinical Trials

Pyrimethamine as an Inhibitor of NRF2 in HPV-unrelated Locally Advanced Head and Neck Squamous Cell Carcinoma

Early Phase 1

Recruiting

Conditions: Head and Neck Cancer
Cancer of the Head and Neck

Interventions: Drug: Pyrimethamine

First Posted Date: 2023-01-10

Last Posted Date: 2024-04-22

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 20

Registration Number: NCT05678348

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

Psilocybin for Major Depressive Disorder

Phase 2

Withdrawn

Conditions: Major Depressive Disorder

Interventions: Drug: Psilocybin

First Posted Date: 2023-01-09

Last Posted Date: 2024-07-25

Lead Sponsor: Washington University School of Medicine

Registration Number: NCT05675800

Visual Aids for Induction of Labor RCT

Not Applicable

Recruiting

Conditions: Induced; Birth

Interventions: Other: Visual aid

First Posted Date: 2023-01-04

Last Posted Date: 2024-02-09

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 84

Registration Number: NCT05671224

Locations: 🇺🇸
Washington University, Saint Louis, Missouri, United States

Migraine in Adolescents

Not Applicable

Recruiting

Conditions: Migraine

Interventions: Device: MRI
Device: Thermal Stimuli
Device: Pressure stimuli
Behavioral: Pain ratings
Behavioral: Pressure pain thresholds (PPT)
Behavioral: Conditioned pain modulation (CPM) efficiency
Diagnostic Test: Hormonal assessment
Behavioral: Migraine-related measures
Behavioral: Neural assessments
Diagnostic Test: Pubertal status

First Posted Date: 2022-12-16

Last Posted Date: 2024-08-15

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 250

Registration Number: NCT05654012

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

Feasibility and Acceptability of Risk Stratification in the Fourth Trimester to Reduce Maternal Morbidity and Mortality

Not Applicable

Completed

Conditions: Hypertensive Disorder of Pregnancy

Interventions: Behavioral: Remote blood pressure monitoring
Diagnostic Test: NT proBNP assessment

First Posted Date: 2022-11-30

Last Posted Date: 2023-11-28

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 180

Registration Number: NCT05631067

Locations: 🇳🇬
University of Abuja Teaching Hospital, Gwagwalada, FCT, Nigeria

Memory-Like Natural Killer Cells With Nivolumab and Relatlimab in Advanced or Metastatic Melanoma After Progression on Checkpoint Inhibitors

Phase 1

Recruiting

Conditions: Advanced Melanoma
Metastatic Melanoma

Interventions: Biological: Cytokine-induced memory-like natural killer cells
Biological: Relatilmab
Biological: Nivolumab

First Posted Date: 2022-11-29

Last Posted Date: 2024-11-08

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 33

Registration Number: NCT05629546

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

Precision Prevention Strategy to Increase Uptake and Engagement in Lung Cancer Screening and Smoking Cessation Treatment

Not Applicable

Conditions: Smoking Cessation
Smoking
Tobacco Use Cessation

Interventions: Behavioral: RiskProfile-Clin
Behavioral: RiskProfile-Gen
Behavioral: Usual Care

First Posted Date: 2022-11-28

Last Posted Date: 2024-11-08

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 915

Registration Number: NCT05627674

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

Adaptive Stereotactic Body Radiation Therapy to the Prostate and Pelvic Nodes With Simultaneous Integrated Boost to the MR-detected Nodule for Patients With High-risk and Unfavorable Intermediate-risk Prostate Cancer

Not Applicable

Recruiting

Conditions: Prostate Cancer
Cancer of the Prostate

Interventions: Device: Ethos Varian treatment system
Radiation: Adaptive stereotactic body radiotherapy
Drug: Androgen deprivation therapy

First Posted Date: 2022-11-28

Last Posted Date: 2024-04-26

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 25

Registration Number: NCT05628363

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

Myocardial Perfusion Imaging Galmydar Rest/Stress

Early Phase 1

Recruiting

Conditions: Coronary Artery Disease

Interventions: Drug: Ga-68 Galmydar
Drug: 13N-ammonia

First Posted Date: 2022-11-23

Last Posted Date: 2024-07-31

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 30

Registration Number: NCT05625490

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

Endometriosis Group Care

Not Applicable

Recruiting

Conditions: Endometriosis
Pelvic Pain

Interventions: Other: Peer Empowered Endometriosis Pain Support (PEEPS)

First Posted Date: 2022-11-21

Last Posted Date: 2023-10-25

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 40

Registration Number: NCT05622955

Locations: 🇺🇸
Washington University in St. Louis, Saint Louis, Missouri, United States

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy